Transcriptional Regulation of PDGF-A and TGF-β by +KTS WT1 Deletion Mutants and a Mutant Mimicking Denys-Drash Syndrome

References

• Call K M, Glaser T, Ito C Y, Buckler A J, Pelletier J, Haber D A, Rose E A, Kral A, Yeger K, Lewis W H. Isolation and characterization of a zine finger polypeptide gene at the human chromosome U Wilms tumor loeus. Cell 1990; 60: 509–520
   PubMed Web of Science ®Google Scholar
• Gessler M, Poustka A, Cavence W, Neve R L, Orkin S H, Brims G A. Homozygous deletion in Wilms tumor of a zine-finger gene identified by chromosome jumping. Nature 1990; 343: 774–778
   PubMed Web of Science ®Google Scholar
• Harber D A, Sohn R L, Buckler A J, Pelletier J, Call K M., Housman D E. Altemative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 1991; 88: 9618–9622
   PubMed Web of Science ®Google Scholar
• Bardeesy N, Falkoff D, Petruzzi M J, Nowak N, Zabel B, Adam M, Aguiar M C, Grundy P, Show T, Pelletier J. Anaplastic Wilms tumor, a subtype displaying poor prognosis, harbors p53 gene mutations. Nat Genet 1994; 7: 91–97
   PubMed Web of Science ®Google Scholar
• Hastic N D. Dominant negative mutations in Wilms tumor (WT1) gene cause Denys-Drash syndrome-proof that a tumor-suppressor gene plays a crucial role in normal genitourinary development. Hum Mol Genet 1992; 1: 293–295
   PubMedGoogle Scholar
• Jadresie L, Leake J, Gordon I, Dillion M J, Grant D B, Pritchand J, Risdon R A, Barratt T M. Clinicopathologic review of twelve children with nephropathy. Wilms tumor and geni tal abnormalities (Drash syndrome). J Pediatr 1990; 117: 117–725
   Web of Science ®Google Scholar
• Kreidberg J A, Sariola H, Loring J M, Maeda M, Pelletier J, Housman D, Jaenisch R. WT1 is required for early kidney development. Cell 1993; 74: 679–691
   PubMed Web of Science ®Google Scholar
• Frasier S, Bashore R A, Mosier H D. Gonadoblastoma associated with pure gonadal dysgenesis in monozygotic twins. J Pediatr 1964; 64: 740–745
   PubMed Web of Science ®Google Scholar
• Kinberg J A, Angle C R, Wilson R B. Nephropathy-gonadal dysgenesis, type 2: renal failure in three siblings with XY dysgenesis in one. Am J Kidney Dis 1987; 9: 501–510
   Web of Science ®Google Scholar
• Barbaux S, Niaudet P, Gubler M C, Grunfeld J P, Jaubert F, Kuttennn F, Fekete C N, Souleyreau Therville N, Thibaud E, Fellous M, McElreavey K. Donor splice-site mutations in WT1 are responsible for Kramer syndrome. Nat Genet 1997; 17: 467–470
   PubMed Web of Science ®Google Scholar
• Eecles M R, Grubb G, Ogawa O, Szeto I, Reeve A E. Cloning of novel Wilms tumor gene (WT1) cDNAs, evidence for antisense transcription of WT1. Oncogene 1994; 9: 2059–2063
   PubMed Web of Science ®Google Scholar
• Sukhatme V P. Early transcriptional events in cell growth the Egr family. J Am Soc Nephrol 1990; 1: 859–866
   PubMed Web of Science ®Google Scholar
• Madden S L, Cook D M, Moms J F, Gashler A, Sukhatmc V P, Rauscher F J, III. Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science 1991; 253: 1550–1553
   PubMed Web of Science ®Google Scholar
• Ruppreeh H D, Drummond I A, Madden S L, Rauscher F J, III, Sukhatme V P. The Wilms tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 1994; 269: 6198–6206
   PubMed Web of Science ®Google Scholar
• Johnson R J, Raines E W, Floege J, Yoshimura A, Pritl P, Alpers C, Ross R. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992; 175: 1413–1416
   PubMed Web of Science ®Google Scholar
• Ciesualdo L, Pinzani M, Floriano J J, Hassan M O, Nagy N U, Schena F P, Emancipator S N, Abboud M E. Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest 1991; 65: 160–167
   PubMed Web of Science ®Google Scholar
• Border W A, Okuda S, Languino L R, Sporn M B, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990; 346: 371–374
   PubMed Web of Science ®Google Scholar
• Gashler A L, Bonthron D T, Madden S L, Rauseher F J, III, Colins T, Sukhatme V P. Human platelet-derived growth factor: A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc Natl Acad Sci US4 1992; 89: 10984–10988
   PubMed Web of Science ®Google Scholar
• Dey B R, Sukhatme V P, Roberts A B, Sporn M B, Rauscher F J, III, Kim S J. Repression of the transforming growth factor-β1 gene by the Wilms tumor suppressor WT1 gene product. Mol Endocrinol 1994; 8: 595–602
   PubMed Web of Science ®Google Scholar
• Clarkson P A, Davies H R, Williams D M, Chaudhary R, Hughes I A, Patterson M N. Mutational screening of the Wilms tumor gene, WT1 in males with genital abnormalities. J Med Genet 1993; 30: 767–772
   PubMed Web of Science ®Google Scholar
• Van Heyningen V. Sugar and spice and all things splice?. Nat Genet 1997; 17: 367–368
   PubMed Web of Science ®Google Scholar
• Kathryn P, Fleming S, Davidson D, Bickmore W, Porteus D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, van Heyningen V, Hastle N. The candidate Wilms tumor gene is involved in genitourinary development. Nature 1990; 346: 194–197
   PubMed Web of Science ®Google Scholar
• Wang Z, Qui Q, Huang J, Gurrier, Deuel T F. Products of alternatively spliced transcripts of the Wilms tumor suppressor gene. WT1, have altered DNA binding specificity and regulate transcription in different ways. Oncogene 1995; 10: 415–422
   PubMed Web of Science ®Google Scholar
• Menke A L, Shvarts A, Riteco N, van Ham R C, van der Eb A J, Jochemsen A G. Wilms tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor. Cancer Res 1997; 57: 1353–1363
   PubMed Web of Science ®Google Scholar
• Ye Y, Raychaudhuri B, Gumey A, Campbell C E, Williams B R. Regulation of WT1 by phosphorylalion inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. EMBO 1996; 15: 5606–5615
   PubMed Web of Science ®Google Scholar
• Fraizer G C, Wu Y J, Hewitt S M, Maity T, Ton C C, Huff V, Saunders G F. Transcnptional regulation of the human Wilms tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter. J Biol Chem 1994; 269: 8892–8900
   PubMed Web of Science ®Google Scholar
• Borel F, Barilla K C, Hamilton T B, Iskandar M, Romaniuk P J. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms tumor suppressor protein WT1. Biochem 1996; 37: 12070–12076
   Google Scholar